Transfusion-dependent Thalassemia
📧 Sign up to get email alerts when something new happens for Transfusion-dependent Thalassemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses [Phase 2]
A Phase 2 trial of twice-daily deferasirox in transfusion-dependent thalassemia patients inadequately responding to high-dose therapy has be…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia [Phase 4]
A Phase 4 trial evaluating whether deferasirox affects endocrine complications in patients with transfusion-dependent thalassemia was withdr…